Work

Prior Case of Resistance on Dolutegravir Plus Lamivudine Dual Therapy

Year: 2020

Type: article

Source: AIDS Research and Human Retroviruses

DOI: 10.1089/aid.2019.0253

Authors: Babafemi O. Taiwo, Miguel E. Quiñones-Mateu, Kimberly Smith, Lu Zheng, Roy Gulick, Amesika N. Nyaku, Paul E. Sax, Belinda Ha, Johnstone Kumwenda, Maxine Olefsky, Catherine Godfrey, Carole Wallis

Institutions: Northwestern University, University of Otago, Harvard University, Weill Cornell Medicine, Rutgers, The State University of New Jersey, Brigham and Women's Hospital, University of Malawi, National Institute of Allergy and Infectious Diseases, Lancet Laboratories

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute of Allergy and Infectious Diseases

Awards: G2501702145, G3922356, G4553935269, G857487509, Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, Statistical and Data Management Center (SDMC), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG)

OpenAlex ID: W3000298146

FWCI: 0.06

Cites: 4

Cited by: 3

Related to: 10